Atlas Trials

Efficacy and Safety of CD7 CAR-T in Newly Diagnosed High-Risk T-LBL/ALL

Clinical trial NCT07476027 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07476027
Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Status
NOT_YET_RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
T Lymphoblastic LymphomaT Acute Lymphoblastic Leukemia
Start date
2026-03-15
Primary completion
2029-04-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.